A promising new treatment for recurrent pediatric brain cancer

(Baylor College of Medicine) Researchers developed a novel approach that delivers appropriately-targeted chimeric antigen receptor (CAR) T cell therapy directly into the cerebrospinal fluid that surrounds recurrent pediatric brain tumors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news